Source: Richard Craver,  WINSTON-SALEM JOURNAL, 3/7/15

The pending sale of Targacept Inc. – Winston-Salem’s biotechnology face for nearly 15 years – signifies both the ending of a high-profile era and a fresh example of the volatility that comes with hitching economic fortunes to the biotech sector.

For more of this story, click here.